Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Hennigsdorf, Germany Clinical Trials

A listing of Hennigsdorf, Germany clinical trials actively recruiting patients volunteers.

RESULTS

Found (25) clinical trials

Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart Failure

Heart failure is a leading cause of death, hospitalisation, impaired quality of life and health expenditure. Symptoms and survival can be significantly improved by implantation of a device for Cardiac Resynchronisation Therapy (CRT). CRT devices are available as biventricular pacemakers (CRT-P) or as significantly more complex and cost-intensive biventricular defibrillators ...

Phase N/A

0.0 miles

Learn More »

tDCS and Speech Therapy to Improve Aphasia

Approximately 25% of all patients after stroke suffer from aphasia. The aphasia could be so severe, that the patient cannot produce any words at all, and so the communication ability is rather poor. In that case speech therapy is the most common therapy, but the functional outcome for the patient ...

Phase N/A

4.92 miles

Learn More »

Enhanced Recovery After Intensive Care (ERIC)

Rationale Survivors of critical illness frequently develop long-term mental, cognitive, and/or physical impairments summarized as Post Intensive Care Syndrome (PICS). On the national society level, Germany uses 10 core QIs that are evidence-based to improve treatment quality at ICUs. Objective To investigate whether a tele-medical intervention delivered at ICU improves ...

Phase N/A

4.92 miles

Learn More »

Efficacy of Herbal Galactagogue Silitidil After Preterm Birth

Mothers of preterm infants born at a gestational age <= 32 wg are asked to participate in this double-blind, randomized, placebo-controlled interventional trial, where they will receive a preparation of the herbal galactogogue Silitidil or placebo over an intervention period of 3 weeks. The influence of the galactagogue will be ...

Phase N/A

4.92 miles

Learn More »

BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Myocardial Infarction

Patients randomized to the BioMonitor arm will receive an implantable cardiac monitor (ICM; BioMonitor) with remote monitoring function (Home Monitoring). If the device detects and reports an arrhythmia, patients will be appropriately examined and treated. Patients randomized to the control arm will receive best proven treatment, but no implantable cardiac ...

Phase N/A

5.21 miles

Learn More »

Effect of Stitch Technique on the Occurrence of Incisional Hernia After Abdominal Wall Closure

The major long term complication of abdominal wall closure after a median laparotomy is the development of an incisional hernia. Several suture technique and suture material have been used but the incidence of this complication still lies between 9 -20%. Synthetic suture material which have become available over the last ...

Phase N/A

5.9 miles

Learn More »

Radical Versus Simple Hysterectomy and Pelvic Node Dissection in Patients With Low-risk Early Stage Cervical Cancer (SHAPE)

At this time, it is not clear which of these approaches best balances the desire to prevent cancer of the cervix from returning with the risks of side effects after surgery and in the long-term.

Phase N/A

8.34 miles

Learn More »

Study to Evaluate Benefit of ProbioSatys on Weight Reduction in Overweight Subjects

ProbioSatys is a probiotic nutritional solution containing a commensal Enterobacteriaceae food grade strain, Hafnia alvei 4597. The microbiome is known to play a crucial role in body weight management and metabolic disease. ProbioSatys mechanism of action relies on bacterial metabolites that send local and central signals via the gut-brain axis ...

Phase N/A

8.46 miles

Learn More »

Tiara Transcatheter Mitral Valve Replacement Study

The TIARA-II study is an international, multicenter, single-arm, prospective, safety and performance clinical study.

Phase N/A

8.89 miles

Learn More »

Decompressive Hemicraniectomy in Intracerebral Hemorrhage

Background Spontaneous intracerebral hemorrhage (ICH) remains a devastating disease with mortality rates up to 52% at 30 days. It is a major public health problem with an annual incidence of 10-30 per 100'000 population, accounting for 2 million (10-15%) of about 15 million strokes worldwide each year. One-third of patients ...

Phase N/A

8.89 miles

Learn More »